Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Korro Bio (KRRO) Return on Equity (2019 - 2025)

Korro Bio (KRRO) has disclosed Return on Equity for 6 consecutive years, with 0.83% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Equity fell 75.0% year-over-year to 0.83%, compared with a TTM value of 0.83% through Sep 2025, down 75.0%, and an annual FY2024 reading of 0.51%, down 51.0% over the prior year.
  • Return on Equity was 0.83% for Q3 2025 at Korro Bio, down from 0.72% in the prior quarter.
  • Across five years, Return on Equity topped out at 6.8% in Q4 2022 and bottomed at 2.49% in Q1 2022.
  • Average Return on Equity over 5 years is 0.09%, with a median of 0.31% recorded in 2021.
  • The sharpest move saw Return on Equity skyrocketed 842bps in 2022, then plummeted -681bps in 2023.
  • Year by year, Return on Equity stood at 1.61% in 2021, then skyrocketed by 521bps to 6.8% in 2022, then crashed by -100bps to 0.0% in 2023, then crashed by -20367bps to 0.49% in 2024, then crashed by -68bps to 0.83% in 2025.
  • Business Quant data shows Return on Equity for KRRO at 0.83% in Q3 2025, 0.72% in Q2 2025, and 0.58% in Q1 2025.